QUANTITATIVE RELATIONSHIP OF CIRCULATING P24 ANTIGEN WITH HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) RNA AND SPECIFIC ANTIBODY IN HIV-INFECTED SUBJECTS RECEIVING ANTIRETROVIRAL THERAPY

被引:23
作者
BROWN, AE
VAHEY, MT
ZHOU, SYJ
CHUNG, RCY
RUIZ, NM
HOFHEINZ, D
LANE, JR
MAYERS, DL
WAGNER, K
FUJIMARAJUSTICE, M
KERNOZEK, P
KOCH, K
BREWER, C
CHUNG, R
SHELLIE, E
LORIZLIM, L
SMALLS, C
HAMILTON, A
BURKE, DS
ROBERTS, CR
ABRAMS, L
MANSFIELD, J
PEARSON, D
WEISLOW, O
FOWLER, A
MERRITT, L
机构
[1] SRA TECHNOL, ROCKVILLE, MD USA
[2] NATL NAVAL MED CTR, BETHESDA, MD USA
[3] WALTER REED ARMY MED CTR, WASHINGTON, DC USA
[4] COULTER IMMUNOL, HIALEAH, FL USA
关键词
D O I
10.1093/infdis/172.4.1091
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To better understand the biologic meaning and potential clinical utility of p24 antigen measurements in human immunodeficiency virus (HIV) infection, p24 antigen and antibody and HIV RNA were quantitated in parallel, Specimens (n = 311) were analyzed from 74 participants in a zidovudine treatment study, Parallel antigen and RNA measurements revealed the frequent occurrence of two types of discordant results, First, p24 antigen was often not detected in samples with high antibody levels even when >10(6) RNA copies/mL were present, Second, in specimens in which p24 antigen was detected, the concentration was greater than expected on the basis of HIV RNA values, These results suggest that optimal use of serum p24 antigen values will require consideration of both specific antibody levels and non-virion associated antigen.
引用
收藏
页码:1091 / 1095
页数:5
相关论文
共 15 条
[1]   PLASMA HIV-1 VIREMIA IN HIV-1 INFECTED INDIVIDUALS ASSESSED BY POLYMERASE CHAIN-REACTION [J].
AOKISEI, S ;
YARCHOAN, R ;
KAGEYAMA, S ;
HOEKZEMA, DT ;
PLUDA, JM ;
WYVILL, KM ;
BRODER, S ;
MITSUYA, H .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (07) :1263-1270
[2]  
ASCHER DP, 1992, J ACQ IMMUN DEF SYND, V5, P1080
[3]  
BROWN AE, 1995, AIDS, V9, P325, DOI 10.1097/00002030-199509040-00002
[4]   VIROLOGICAL AND IMMUNOLOGICAL CHARACTERIZATION OF LONG-TERM SURVIVORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
CAO, YZ ;
QIN, LM ;
ZHANG, LQ ;
SAFRIT, J ;
HO, DD .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (04) :201-208
[5]   SERUM P24 ANTIGEN LEVEL AS AN INTERMEDIATE END-POINT IN CLINICAL-TRIALS OF ZIDOVUDINE IN PEOPLE INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
DEGRUTTOLA, V ;
BECKETT, LA ;
COOMBS, RW ;
ARDUINO, JM ;
BALFOUR, HH ;
RASHEED, S ;
HOLLINGER, FB ;
FISCHL, MA ;
VOLBERDING, P ;
GROUP, TACT .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (04) :713-721
[6]  
ERB P, 1994, J ACQ IMMUN DEF SYND, V7, P261
[7]   ASSOCIATION OF ANTIBODY TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CORE PROTEIN (P24), CD4+ LYMPHOCYTE NUMBER, AND AIDS-FREE TIME [J].
FARZADEGAN, H ;
CHMIEL, JS ;
ODAKA, N ;
WARD, L ;
POGGENSEE, L ;
SAAH, A ;
PHAIR, JP .
JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (06) :1217-1222
[8]   RAPID TURNOVER OF PLASMA VIRIONS AND CD4 LYMPHOCYTES IN HIV-1 INFECTION [J].
HO, DD ;
NEUMANN, AU ;
PERELSON, AS ;
CHEN, W ;
LEONARD, JM ;
MARKOWITZ, M .
NATURE, 1995, 373 (6510) :123-126
[9]   FACTORS UNDERLYING SPONTANEOUS INACTIVATION AND SUSCEPTIBILITY TO NEUTRALIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS [J].
LAYNE, SP ;
MERGES, MJ ;
DEMBO, M ;
SPOUGE, JL ;
CONLEY, SR ;
MOORE, JP ;
RAINA, JL ;
RENZ, H ;
GELDERBLOM, HR ;
NARA, PL .
VIROLOGY, 1992, 189 (02) :695-714
[10]   MULTICENTER EVALUATION OF QUANTIFICATION METHODS FOR PLASMA HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA [J].
LIN, HJ ;
MYERS, LE ;
YENLIEBERMAN, B ;
HOLLINGER, FB ;
HENRARD, D ;
HOOPER, CJ ;
KOKKA, R ;
KWOK, S ;
RASHEED, S ;
VAHEY, M ;
WINTERS, MA ;
MCQUAY, LJ ;
NARA, PL ;
REICHELDERFER, P ;
COOMBS, RW ;
JACKSON, JB .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (03) :553-562